Login / Signup

The Development of Cuba's Biotechnology: Mechanisms and Challenges.

Omar Everleny Perez VillanuevaJuan Carlos Albizu-Campos Espiñeira
Published in: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2023)
Cuba faces a dilemma between continuing its current portfolio of biotechnology drugs and vaccines with lower profitability or renewing its product portfolio with the associated costs and risks.
Keyphrases
  • human health
  • medical education
  • drug induced